Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-2-2
|
pubmed:abstractText |
Two studies were conducted to investigate the haemodynamic effects of IGF-I and its analogue LR3IGF-I in normal anaesthetised rats. Infusion of IGF-I intravenously, at a dose of 125 micrograms/kg/h, for 20 min in the first study resulted in renal blood flow being significantly elevated by 35% above baseline. Mean arterial blood pressure (MABP) at this IGF-I dose fell by 18% of baseline, with LR3IGF-I also causing a significant decline in MABP (by 15%) at the dose of 125 micrograms/kg/h. In the second study the intravenous administration of IGF-I or LR3IGF-I, at a dose of 125 micrograms/kg/h, over a period of 60 min, resulted in MABP being significantly lowered by 25% of baseline values. Regional blood flow rates were determined using radioactive microspheres, 15 microns in diameter, injected systemically at the end of the peptide infusion period. The gastrocnemius, a representative skeletal muscle, was the only vascular region to show a significant increase in blood flow after IGF-I (by 58%) or LR3IGF-1 (by 308%) infusion. Vascular resistance in the brain was significantly reduced after infusion of IGF-I (by 60%) or LR3IGF-I (by 48%) as compared with vehicle. Skeletal muscle vascular resistance was also reduced by IGF-I (by 41%) and more particularly by LR3IGF-I (by 77%) in comparison to vehicle. These alterations to vascular tone produced by IGF infusion may be related to the central nervous system and systemic cardiovascular side-effects that have been reported during IGF-I administration in humans.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-0795
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
155
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
351-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9415069-Animals,
pubmed-meshheading:9415069-Blood Pressure,
pubmed-meshheading:9415069-Brain,
pubmed-meshheading:9415069-Dose-Response Relationship, Drug,
pubmed-meshheading:9415069-Female,
pubmed-meshheading:9415069-Hemodynamics,
pubmed-meshheading:9415069-Infusions, Intravenous,
pubmed-meshheading:9415069-Insulin-Like Growth Factor I,
pubmed-meshheading:9415069-Kidney,
pubmed-meshheading:9415069-Muscle, Skeletal,
pubmed-meshheading:9415069-Rats,
pubmed-meshheading:9415069-Rats, Sprague-Dawley,
pubmed-meshheading:9415069-Regional Blood Flow,
pubmed-meshheading:9415069-Vascular Resistance
|
pubmed:year |
1997
|
pubmed:articleTitle |
Effects of insulin-like growth factor-I and LR3IGF-I on regional blood flow in normal rats.
|
pubmed:affiliation |
Cooperative Research Centre for Tissue Growth and Repair at the Child Health Research Institute, North Adelaide, South Australia, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|